The deal, through IKS Health’s US subsidiary, will be funded by a loan of up to $670 million secured for a five-year term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results